Suchergebnisse - "Venitz, Jürgen"

PubPharm (13)

1

Population pharmacokinetic analysis of sorafenib in patients with solid tumours

enthalten in: British journal of clinical pharmacology | 2011

von Jain, L. | Woo, S. | Gardner, E. | +8

2

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer

enthalten in: BJU international | 2009

von Aragon-Ching, J. | Jain, L. | Gulley, J. | +9

3

A phase II clinical trial of sorafenib in androgen-independent prostate cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2008

von Dahut, W. | Scripture, C. | Posadas, E. | +12

4

Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2-methoxyestradiol

enthalten in: Journal of pharmaceutical sciences | 2007

von Lakhani, N. | Sparreboom, A. | Xu, X. | +4

5

Randomized discontinuation trial of sorafenib (BAY 43-9006)

enthalten in: Cancer biology & therapy | 2006

von Jain, L. | Venitz, J. | Figg, W.

6

Factors affecting the pharmacokinetic profile of MS-275, a novel histone deacetylase inhibitor, in patients with cancer

enthalten in: Investigational new drugs | 2006

von Acharya, M. | Karp, J. | Sausville, E. | +6

7

Plasma protein binding of the investigational anticancer agent 2-methoxyestradiol

enthalten in: Anti-cancer drugs | 2006

von Lakhani, N. | Sparreboom, A. | Venitz, J. | +2

8

Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors

enthalten in: Cancer biology & therapy | 2006

von Dahut, W. | Lakhani, N. | Gulley, J. | +11

9

Rational development of histone deacetylase inhibitors as anticancer agents : a review

enthalten in: Molecular pharmacology | 2005

von Acharya, M. | Sparreboom, A. | Venitz, J. | +1

10

Chemically modified tetracyclines as inhibitors of matrix metalloproteinases

enthalten in: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy | 2004

von Acharya, M. | Venitz, J. | Figg, W. | +1